Our findings suggest that all severe COVID-19 patients, regardless of existing immunosuppression or cancer diagnoses, experience CD8 + T cell depletion, higher IL-6 concentrations, and importantly, delayed type I IFN peaks. Here, IL6 is linked to COVID-19.